From Milo to miso: The evolution of the Kiwi supermarket shop
Take a peek inside a New Zealand shopping trolley today and you'll find oat milk, tofu, Korean noodles, gluten-free crackers, probiotic soda, and – if we're honest – probably still a block of cheese and a packet of chippies. We're a nation
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Korea Herald
13 minutes ago
- Korea Herald
CGBio launches China joint venture to expand regenerative medicine reach
Korean regenerative medicine company CGBio, affiliated with Daewoong Pharmaceutical, announced Monday the establishment of Sol Cent Bio Co. Ltd., a joint venture with Chinese orthopedic device maker Shanghai Sanyou Medical, marking its full-scale entry into the Chinese regenerative medicine market. The new company will localize the production of advanced regenerative products and medical devices, including human tissue grafts and stem cell isolation systems, to meet China's growing clinical demand. Shanghai Sanyou Medical, a publicly listed company specializing in spinal and trauma care devices, brings strong manufacturing capabilities and a nationwide hospital network to the partnership. By combining CGBio's proprietary technologies with Sanyou's local expertise, Sol Cent Bio aims to accelerate regulatory approvals and build a stable supply chain within China. Initial offerings will include allogeneic bone grafts and acellular dermal matrices, widely used in bone regeneration, burn care and reconstructive surgery. The venture will also produce stem cell separation systems and other regenerative tools developed by CGBio and its subsidiary, CGMedtech. Through the joint venture, CGBio aims to expand its global footprint and deliver regenerative solutions tailored to Chinese patients and providers, while improving cost competitiveness under China's volume-based procurement system. 'The joint venture with Sanyou Medical marks a strategic shift, combining our technology with local manufacturing and sales strength,' said CGBio CEO Yu Hyun-seung. 'Local production will enhance supply stability and responsiveness, setting a new standard in Asia's regenerative medicine market.'
Korea Herald
15 minutes ago
- Korea Herald
OLED growth dims as Trump tariffs threaten smartphone sales
Concerns are mounting over the potential slowdown in global smartphone shipments, triggered by US President Donald Trump's escalating tariff policies, which may in turn dampen the growth momentum of Korea's OLED display industry. According to market tracker Counterpoint Research on Monday, the global smartphone shipment growth forecast for this year has been revised down from 4.2 percent to 1.9 percent. The downgrade was attributed to new uncertainties surrounding US tariffs, the report said. Apple, the single largest buyer in the OLED market, remains at the center of attention as Korean panel suppliers closely monitor the unfolding trade developments. Another research firm, Omdia, also lowered its forecast for smartphone panel market growth, from 5 percent to 4 percent, citing weakening demand. Smartphone displays, which account for the largest share of the overall display market, are expected to see declining revenues. Market watchers warn that if tariffs are imposed on finished products such as smartphones, it could lead to higher retail prices and dampened consumer demand, and possibly force smartphone makers to pass the burden down to their suppliers. Currently, it is estimated that Samsung Display supplies about half of OLED panels for iPhones, followed by LG Display with 30 percent and China's BOE with 20 percent. For premium models such as the iPhone Pro, Korean firms are believed to be the sole suppliers. 'Should the Trump administration implement tariffs on smartphones, device manufacturers are likely to consider price hikes and component cost reductions to offset the impact,' said Im Mi-hye, a senior researcher at the Korea Eximbank's Overseas Economic Research Institute. 'Display makers will need to further intensify cost-cutting efforts to stay competitive.' Meanwhile, Chinese panel makers -- less reliant on Apple -- are expected to continue expanding their market share by catering primarily to local smartphone brands. Despite the overall market downgrade, Counterpoint Research forecasted Huawei's shipments to rise by 11 percent this year, saying that supply bottlenecks for key components are expected to ease by year-end, allowing Huawei to secure a solid foothold in China's mid- to low-end market. The TV OLED segment, where Korean companies hold a production monopoly, is also facing headwinds. In the first quarter of this year, average selling prices of OLED TV panels fell by 5 to 9 percent compared to a year ago, continuing a downward trend that began in the third quarter of 2023. 'In the short term, the US tariff policy may have a limited impact on Korea's display industry,' said an industry source who requested anonymity. 'However, in the long term, fears of inflation and global economic slowdown are likely to dampen demand for IT devices -- and with it, the demand and pricing power for displays as well.'
![[Photo News] K-style ramyeon bar](/_next/image?url=https%3A%2F%2Fwimg.heraldcorp.com%2Fnews%2Fcms%2F2025%2F06%2F09%2Fnews-p.v1.20250609.dec6d0c05f21438997d6cf0272c1fb61_T1.jpg&w=3840&q=100)
Korea Herald
27 minutes ago
- Korea Herald
[Photo News] K-style ramyeon bar
Nongshim opens its "Shin Ramyun Bunsik" store in Harajuku, Tokyo, Monday — a casual Korean eatery specializing in Korean ramyeon. As its first location in Asia and second global outlet following the April launch in Peru, the store features a ramyeon bar where visitors can cook and enjoy Nongshim's noodle products. The space resembles Korean street food stalls, complete with Korean-inspired interiors and Instagram-friendly photo zones. Located in one of Tokyo's trendiest neighborhoods, the store reflects Nongshim's broader strategy to reach global consumers through immersive, experience-based marketing. (Nongshim)
